Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lachance (Shandong Longchang Animal Health Product) is a leading biotechnology company specializing in the research, development, and production of functional feed additives for the global animal health industry. The company is a pioneer in bile acid technology, being the first in China to receive the Class I New Feed Additive certificate for these compounds. Its core product portfolio, centered on bile acids and natural plant extracts, is designed to improve fat metabolism, protect hepatobiliary health, and enhance growth performance in livestock, poultry, and aquaculture. Backed by prominent venture capital firms such as IDG Capital, Lachance operates advanced manufacturing facilities and a dedicated R&D center in Shandong. The company's solutions are integral to sustainable animal production, focusing on antibiotic reduction and optimized nutritional efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Longchang.